John Jordan
Vice President of Investor Relations
Replay available
Viridian Therapeutics, Inc. (VRDN) Q2 2022 Earnings Call
Viridian Therapeutics, Inc. (NASDAQ: VRDN) Q2 2022 earnings conference call, held 2022-08-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jonathan Violin
President and Chief Executive Officer
Barrett Katz
Chief Medical Officer
Raymond Douglas
Director, Thyroid Eye Disease Program at Cedars-Sinai Hospital
Christian Humer
Chief Financial Officer and Chief Business Officer
Chris Howerton
Analyst, Jefferies
Thomas Smith
Analyst, SVB Securities
Gavin Clark-Gartner
Analyst, Evercore ISI
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Viridian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.191 Greetings and welcome to the Viridian Therapeutics conference call. 00:00:04.191 -- 00:00:07.833 At this time, all participants are in a listen-only mode. 00:00:07.833 -- 00:00:11.495 A question and answer session will follow the formal presentation. 00:00:11.495 -- 00:00:15.457 If anyone should require operator assistance during the conference, please press star 00:00:15.457 -- 00:00:21.160 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.160 -- 00:00:25.642 I would now like to turn the call over to John Jordan, Vice President of Investor Relations. 00:00:25.642 -- 00:00:28.483 Thank you. You may begin. 00:00:28.581 -- 00:00:32.023 Thank you, Daryl. Good morning, everyone, and welcome to the Verdean conference call 00:00:32.023 -- 00:00:36.724 to discuss the initial clinical data for VRDN001 00:00:36.806 -- 00:00:41.809 in patients with thyroid eye disease. Before we begin, I would like to 00:00:41.809 -- 00:00:46.331 remind everyone that this conference call and webcast will contain forward-looking statements 00:00:46.331 -- 00:00:50.593 about the company. These statements are subject to risks and uncertainties that could 00:00:50.593 -- 00:00:55.056 cause actual results to differ. Please note that these forward-looking statements reflect 00:00:55.056 -- 00:01:00.544 our opinions only as of today. Except as required by law, we specifically disclaim 00:01:00.544 -- 00:01:05.625 any obligation to update or revise these forward-looking statements in light of new information 00:01:05.625 -- 00:01:10.986 or future events. Factors that could cause actual results or outcomes to differ materially 00:01:10.986 -- 00:01:15.767 from those expressed in or implied by such forward-looking statements are...